Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.2 and the v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:07:49.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T19:19:55.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T17:20:47.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and a prior funding notice (v3.4.1) removed; these administrative changes do not affect the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T09:21:01.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new government funding notice about the NIH Clinical Center operating status has been added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-04T05:23:18.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Show glossary option and color-coding explanations have been added to the study history page, clarifying how additions (green) and deletions (red) are displayed. The revision label updated to v3.4.0 and the 'No FEAR Act data' wording was removed in favor of the current phrasing. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T02:30:32.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.